Pitt Street Research | Stock research
Proteomics International Laboratories.png

Proteomics International Laboratories

Proteomics International Laboratories (ASX: PIQ) is a biotech company that is developing precision diagnostic medical tests that identify protein biomarkers via blood samples and consequently, medical indications. The company is poised to commercialise 3 of them in the first half of CY25 (1H25) – PromarkerD for Diabetic Kidney Disease (DKD), PromarkerEndo for Endometriosis and PromarkerEso and Esophageal cancer – all named after the Promarker platform these tests were developed from.

Proteomics International Laboratories (ASX: PIQ)

 

Proteomics International Laboratories (ASX: PIQ) is a biotech company that is developing precision diagnostic medical tests that identify protein biomarkers via blood samples and consequently, medical indications. The company is poised to commercialise 3 of them in the first half of CY25 (1H25) – PromarkerD for Diabetic Kidney Disease (DKD), PromarkerEndo for Endometriosis and PromarkerEso and Esophageal cancer – all named after the Promarker platform these tests were developed from.